AEGON Asset Management (UK)’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

AEGON Asset Management (UK)’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-9,367	Closed	-$1.07M	–	233
2016 Q1	$1.07M	Buy	9,367 +2,400	+34%	+$282K	0.03%	152
2015 Q4	$991K	Buy	+6,967	New	+$804K	0.03%	163

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

ICP

Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AEGON Asset Management (UK)'s CBPO Position: Q2 2016 in Review

AEGON Asset Management (UK) sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2016, closing a stake of 9,367 shares — an estimated $1.07M sold.

AEGON Asset Management (UK) first reported a position in CBPO in Q4 2015 and held it in 2 quarters. The position peaked at $1.07M in Q1 2016. 138 funds tracked by Wall St. Rank hold CBPO as of Q2 2016.

AEGON Asset Management (UK) reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
AEGON Asset Management (UK) sold 9,367 China Biologic Products Holdings, Inc. shares in Q2 2016, an estimated $1.07M.
AEGON Asset Management (UK) first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 2 quarters.
AEGON Asset Management (UK)'s China Biologic Products Holdings, Inc. position peaked at $1.07M in Q1 2016.
138 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2016.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2016, filed 8 Sep 2016.